Comorbidity influences therapeutic approach in multiple sclerosis

Clin Neurol Neurosurg. 2017 Apr:155:14-16. doi: 10.1016/j.clineuro.2017.02.003. Epub 2017 Feb 11.
No abstract available

Keywords: Dimethylfumarate; Interferon; Multiple sclerosis; Systemic sclerosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Comorbidity
  • Dimethyl Fumarate / therapeutic use*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Multiple Sclerosis, Relapsing-Remitting / epidemiology
  • Scleroderma, Systemic / drug therapy*
  • Scleroderma, Systemic / epidemiology

Substances

  • Immunosuppressive Agents
  • Dimethyl Fumarate